High Uric Acid (8.4 mg/dL): Risks and Management
A serum uric acid level of 8.4 mg/dL is elevated (normal: men <7.0, women <6.0 mg/dL). Hyperuricemia promotes monosodium urate crystal deposition, causing gout flares and tophi. It is also independently associated with:
- Chronic kidney disease (urate nephropathy, nephrolithiasis).
- Cardiovascular disease (hypertension, coronary artery disease, heart failure).
- Metabolic syndrome (insulin resistance, obesity, dyslipidemia).
Management
- Lifestyle: Low-purine diet (limit red meat, organ meats, shellfish, alcohol—especially beer), hydration (≥2 L water/day), weight loss if overweight.
- Medications: Urate-lowering therapy (allopurinol first-line, febuxostat if intolerant) indicated for frequent flares, tophi, CKD, or urolithiasis. Target urate <6 mg/dL (<5 mg/dL if tophi).
- Prophylaxis: Colchicine 0.6 mg daily/biweekly during ULT initiation to prevent flares.
- Monitor: Serum urate, renal function, CBC periodically.
Asymptomatic hyperuricemia alone doesn't always require pharmacotherapy; shared decision-making with a rheumatologist or PCP is advised.
Urinary Disorders - Related Articles
- Urea in Urine After Meat Consumption: Understanding the Connection
- Urinary Tract Infection (UTI): Symptoms, Causes & Treatment
- Urethral Stretching for Intercourse: Risks and Considerations
- Understanding Polyuria and Urinary Tract Infections (UTIs)
- Understanding Incontinence: Types, Causes & When to Seek Help
- Managing Indwelling Urinary Catheters: A Comprehensive Guide for Long-Term Use
- Urinary Catheter Care: Cleaning & Infection Prevention
